6 Mar 2022
TUESDAY DEADLINE: Talis Biomedical Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – TLIS
Author: admintech | Filed under: Press ReleaseSAN DIEGO, March 5, 2022 /PRNewswire/ — Robbins Geller Rudman & Dowd LLP announces that purchasers of Talis Biomedical Corporation (NASDAQ: TLIS) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in…